Seaport Therapeutics, Inc.
CIK:
0002042347
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
State of Incorporation
DE
Business Address
6 TIDE STREET, BOSTON, MA, 02110
Mailing Address
6 TIDE STREET, BOSTON, MA, 02110
Phone
617-807-4062
Fiscal Year End
1231
EIN
992235719
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | April 10, 2026 | View on SEC |
IPO Filings
S-1
April 10, 2026
- Proprietary 'Glyph' platform leverages the lymphatic system to improve drug absorption and reduce side effects.
- Led by a high-profile management team with a proven track record, including co-founders of the $14B Karuna Therapeutics acquisition.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.